STOCK TITAN

Moderna (MRNA) president exercises RSUs, reports tax share withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Moderna, Inc. president Stephen Hoge reported routine equity compensation activity. He exercised 9,282 restricted stock units, which convert into common stock on a one-for-one basis, adding the same number of common shares.

In connection with this vesting, 4,488 shares were withheld at $47.19 per share to satisfy tax withholding obligations, a non‑market disposition. After these transactions, Hoge directly holds 1,483,848 shares of common stock and has 102,111 restricted stock units outstanding. Additional indirect common stock holdings are reported by a family trust and by Valhalla, LLC, with beneficial ownership of the trust shares disclaimed except for any pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Hoge Stephen
Role President
Type Security Shares Price Value
Exercise Restricted Stock Units 9,282 $0.00 --
Exercise Common Stock 9,282 $0.00 --
Tax Withholding Common Stock 4,488 $47.19 $212K
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock Units — 102,111 shares (Direct, null); Common Stock — 1,488,336 shares (Direct, null); Common Stock — 4,116 shares (Indirect, By Valhalla, LLC)
Footnotes (1)
  1. Restricted stock units convert into common stock on a one-for-one basis. Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
RSUs exercised 9,282 units Restricted stock units converted one-for-one into common stock
Shares withheld for taxes 4,488 shares Withheld at $47.19 per share to satisfy tax obligations
Tax withholding price $47.19/share Value applied to 4,488 withheld shares
Direct common shares after transactions 1,483,848 shares Direct Moderna common stock held by Stephen Hoge following Form 4 activity
Indirect trust holdings 151,933 shares Common stock held by a family trust; beneficial ownership largely disclaimed
Indirect Valhalla, LLC holdings 4,116 shares Common stock held indirectly through Valhalla, LLC
Remaining RSUs 102,111 units Restricted stock units remaining outstanding after the 9,282-unit vesting
Initial RSU vesting date March 1, 2026 25% of the restricted stock unit award vested on this date
Restricted stock units financial
"Restricted stock units convert into common stock on a one-for-one basis."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations"
Section 16 beneficial ownership regulatory
"The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein"
pecuniary interest financial
"except to the extent of his pecuniary interest therein, if any"
vesting financial
"25% of the shares subject to this restricted stock unit award vested on March 1, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hoge Stephen

(Last)(First)(Middle)
C/O MODERNA, INC.
325 BINNEY STREET

(Street)
CAMBRIDGE MASSACHUSETTS 02142

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Moderna, Inc. [ MRNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/01/2026M(1)9,282A(1)1,488,336D
Common Stock06/01/2026F(2)4,488D$47.191,483,848D
Common Stock4,116IBy Valhalla, LLC
Common Stock151,933IBy Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)06/01/2026M(1)9,282 (4) (4)Common Stock9,282$0102,111D
Explanation of Responses:
1. Restricted stock units convert into common stock on a one-for-one basis.
2. Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
3. These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
4. 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
/s/ James Dillon, as Attorney-in-Fact06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Moderna (MRNA) president Stephen Hoge report?

Stephen Hoge reported an exercise of 9,282 restricted stock units into common stock and a related tax withholding of 4,488 shares at $47.19. These actions reflect routine equity compensation vesting rather than open-market buying or selling activity.

How many Moderna (MRNA) shares does Stephen Hoge hold after this Form 4?

After the reported transactions, Stephen Hoge directly holds 1,483,848 shares of Moderna common stock. He also reports additional indirect holdings through a family trust and Valhalla, LLC, plus 102,111 remaining restricted stock units subject to future vesting.

Was Stephen Hoge’s Moderna (MRNA) share disposition an open-market sale?

The filing shows no open-market sale. Instead, 4,488 shares were withheld at $47.19 per share to cover tax obligations on vested restricted stock units, which is treated as a tax-withholding disposition rather than discretionary selling in the market.

What happens to Moderna (MRNA) restricted stock units when they vest for Stephen Hoge?

The restricted stock units convert into Moderna common stock on a one-for-one basis upon vesting. In this case, 9,282 restricted stock units vested and converted into 9,282 common shares, with a portion withheld to satisfy Hoge’s related tax liabilities.

How are Stephen Hoge’s indirect Moderna (MRNA) holdings structured?

Indirect holdings include shares held by a trust for the benefit of his spouse and children and by Valhalla, LLC. For the trust position, Hoge disclaims Section 16 beneficial ownership except to the extent of any pecuniary interest he may have in those securities.

What is the vesting schedule for Stephen Hoge’s Moderna (MRNA) restricted stock units?

According to the filing, 25% of the shares subject to the restricted stock unit award vested on March 1, 2026. The remaining units are scheduled to vest in twelve equal quarterly installments following that initial vesting date, subject to continued conditions.